C

Curvebeam AI Ltd
ASX:CVB

Watchlist Manager
Curvebeam AI Ltd
ASX:CVB
Watchlist
Price: 0.125 AUD 8.7% Market Closed
Market Cap: 48.4m AUD
Have any thoughts about
Curvebeam AI Ltd?
Write Note

Net Margin
Curvebeam AI Ltd

-353.9%
Current
-505%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-353.9%
=
Net Income
-23.1m
/
Revenue
6.5m

Net Margin Across Competitors

Country US
Market Cap 48.4m AUD
Net Margin
-354%
Country US
Market Cap 198.1B USD
Net Margin
14%
Country US
Market Cap 186.8B USD
Net Margin
29%
Country US
Market Cap 139B USD
Net Margin
16%
Country US
Market Cap 131.1B USD
Net Margin
11%
Country IE
Market Cap 103.9B USD
Net Margin
13%
Country US
Market Cap 65.8B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.1B USD
Net Margin
74%
Country CN
Market Cap 303.4B CNY
Net Margin
33%
Country US
Market Cap 36.1B USD
Net Margin
9%
No Stocks Found

Curvebeam AI Ltd
Glance View

Market Cap
48.4m AUD
Industry
Health Care

Curvebeam AI Ltd is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam computed tomography (CT) imaging systems for the orthopedic specialties. The firm is engaged in providing point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI). Its product categories include orthopedics and bone health. Its orthopedics products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care. OssView Bone Fragility software analyzes HR-pQCT images to measure the bone microarchitecture.

CVB Intrinsic Value
0.288 AUD
Undervaluation 57%
Intrinsic Value
Price
C

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-353.9%
=
Net Income
-23.1m
/
Revenue
6.5m
What is the Net Margin of Curvebeam AI Ltd?

Based on Curvebeam AI Ltd's most recent financial statements, the company has Net Margin of -353.9%.